scispace - formally typeset
K

Karine Perlemoine

Researcher at University of Paris

Publications -  52
Citations -  3287

Karine Perlemoine is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 35 publications receiving 2795 citations. Previous affiliations of Karine Perlemoine include Paris Descartes University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

TL;DR: Functional studies showed that the activating Ser45 beta-catenin mutation found in the adrenocortical cancer H295R cell line leads to constitutive activation of T-cell factor-dependent transcription, the first molecular defect to be reported with the same prevalence in both benign and malignant adrenOCortical tumors.
Journal Article

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity

TL;DR: It is concluded that somatic allelic losses of the 17q22-24 region, PRKAR1A-inactivating mutations or down-regulation, and corresponding PKA activity changes are present in at least some sporadic adrenocortical tumors, especially those with a PPNAD-like clinical presentation of CS.
Journal ArticleDOI

Mutations of the PRKAR1A Gene in Cushing's Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease

TL;DR: Genetic analysis can be of help to the clinician in the diagnosis of this difficult form of adrenal Cushing's syndrome, and the wild-type allele can be inactivated by somatic mutations, consistent with the hypothesis of the gene being a tumor suppressor gene.